Cargando…

Comprehensive Physicochemical Characterization, In Vitro Membrane Permeation, and In Vitro Human Skin Cell Culture of a Novel TOPK Inhibitor, HI-TOPK-032

Nonmelanoma skin cancers (NMSC) are the most common skin cancers, and about 5.4 million people are diagnosed each year in the United States. A newly developed T-lymphokine-activated killer cell-originated protein kinase (TOPK) inhibitor, HI-TOPK-032, is effective in suppressing colon cancer cell gro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eedara, Basanth Babu, Manivannan, Bhagyashree, Alabsi, Wafaa, Sun, Bo, Curiel-Lewandrowski, Clara, Zhang, Tianshun, Bode, Ann M., Mansour, Heidi M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650786/ https://www.ncbi.nlm.nih.gov/pubmed/37958502 http://dx.doi.org/10.3390/ijms242115515

Ejemplares similares

Design, Physicochemical Characterization, and In Vitro Permeation of Innovative Resatorvid Topical Formulations for Targeted Skin Drug Delivery
por: Ruiz, Victor H., et al.
Publicado: (2022)

Targeting PRPK and TOPK for skin cancer prevention and therapy
por: Roh, Eunmiri, et al.
Publicado: (2018)

Innovative Rocuronium Bromide Topical Formulation for Targeted Skin Drug Delivery: Design, Comprehensive Characterization, In Vitro 2D/3D Human Cell Culture and Permeation
por: Ruiz, Victor H., et al.
Publicado: (2023)

Phosphorylation of TOPK at Y74, Y272 by Src increases the stability of TOPK and promotes tumorigenesis of colon
por: Xiao, Juanjuan, et al.
Publicado: (2016)

PBK/TOPK Inhibitor Suppresses the Progression of Prolactinomas
por: Zhu, Kejing, et al.
Publicado: (2022)

TOPK and PTEN participate in CHFR mediated mitotic checkpoint()
por: Shinde, Swapnil R., et al.
Publicado: (2013)

PBK/TOPK Expression Predicts Prognosis in Oral Cancer
por: Chang, Chin-Fang, et al.
Publicado: (2016)

PBK/TOPK: A Therapeutic Target Worthy of Attention
por: Han, Ziping, et al.
Publicado: (2021)

Nose-to-Brain Delivery of Therapeutic Peptides as Nasal Aerosols
por: Alabsi, Wafaa, et al.
Publicado: (2022)

PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential
por: Huang, Hai, et al.
Publicado: (2021)

PBK/TOPK mediates geranylgeranylation signaling for breast cancer cell proliferation
por: Dou, Xiaoyan, et al.
Publicado: (2015)

Role of TOPK in lipopolysaccharide-induced breast cancer cell migration and invasion
por: Seol, Min-Ah, et al.
Publicado: (2017)

Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo
por: Joel, Mrinal, et al.
Publicado: (2015)

Inhalation Delivery for the Treatment and Prevention of COVID-19 Infection
por: Eedara, Basanth Babu, et al.
Publicado: (2021)

TOPK is highly expressed in circulating tumor cells, enabling metastasis of prostate cancer
por: Sun, Huimin, et al.
Publicado: (2015)

TOPK inhibits autophagy by phosphorylating ULK1 and promotes glioma resistance to TMZ
por: Lu, Hui, et al.
Publicado: (2019)

TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy
por: Pirovano, Giacomo, et al.
Publicado: (2017)

FYN/TOPK/HSPB1 axis facilitates the proliferation and metastasis of gastric cancer
por: Peng, SanFei, et al.
Publicado: (2023)

PBK/TOPK inhibitor OTS964 resistance is mediated by ABCB1-dependent transport function in cancer: in vitro and in vivo study
por: Yang, Yuqi, et al.
Publicado: (2022)

Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma
por: Ohashi, Takuma, et al.
Publicado: (2017)

PBK/TOPK overexpression and survival in solid tumors: A PRISMA-compliant meta-analysis
por: Xu, Ming, et al.
Publicado: (2019)

T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics
por: Herbert, Katharine J., et al.
Publicado: (2018)

Potent anti‐myeloma activity of the TOPK inhibitor OTS514 in pre‐clinical models
por: Stefka, Andrew T., et al.
Publicado: (2019)

Targeting TOPK sensitises tumour cells to radiation-induced damage by enhancing replication stress
por: Herbert, Katharine J., et al.
Publicado: (2020)

OTS964, a TOPK Inhibitor, Is Susceptible to ABCG2-Mediated Drug Resistance
por: Yang, Yuqi, et al.
Publicado: (2021)

PBK/TOPK Is a Favorable Prognostic Biomarker Correlated with Antitumor Immunity in Colon Cancers
por: Lee, Dong-Hee, et al.
Publicado: (2022)

Inhibiting ALK-TOPK signaling pathway promotes cell apoptosis of ALK-positive NSCLC
por: Xiao, Juanjuan, et al.
Publicado: (2022)

Erratum to: TOPK Activation Exerts Protective Effects on Cisplatin-induced Acute Kidney Injury
por: Zhang, Hui, et al.
Publicado: (2022)

TOPK promotes the growth of esophageal cancer in vitro and in vivo by enhancing YB1/eEF1A1 signal pathway
por: Wu, Wenjie, et al.
Publicado: (2023)

T‐LAK cell‐originated protein kinase (TOPK) is a Novel Prognostic and Therapeutic Target in Chordoma
por: Thanindratarn, Pichaya, et al.
Publicado: (2020)

T‐LAK cell‐originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma
por: Thanindratarn, Pichaya, et al.
Publicado: (2021)

Overexpression of PBK/TOPK relates to poor prognosis of patients with breast cancer: a retrospective analysis
por: Qiao, Liang, et al.
Publicado: (2022)

TOPK promotes lung cancer resistance to EGFR tyrosine kinase inhibitors by phosphorylating and activating c-Jun
por: Li, Ying, et al.
Publicado: (2016)

Oncogenic roles of TOPK and MELK, and effective growth suppression by small molecular inhibitors in kidney cancer cells
por: Kato, Taigo, et al.
Publicado: (2016)

Targeting the COX2/MET/TOPK signaling axis induces apoptosis in gefitinib-resistant NSCLC cells
por: Xiao, Juanjuan, et al.
Publicado: (2019)

TOPK/PBK is phosphorylated by ERK2 at serine 32, promotes tumorigenesis and is involved in sorafenib resistance in RCC
por: Sun, Huimin, et al.
Publicado: (2022)

TOPK mediates immune evasion of renal cell carcinoma via upregulating the expression of PD-L1
por: Li, Jinxin, et al.
Publicado: (2023)

Glycycoumarin Sensitizes Liver Cancer Cells to ABT-737 by Targeting De Novo Lipogenesis and TOPK-Survivin Axis
por: Zhang, Enxiang, et al.
Publicado: (2018)

Prognostic Value of PDZ-Binding Kinase/T-LAK Cell-Originated Protein Kinase (PBK/TOPK) in Patients with Cancer
por: Zhang, Yi, et al.
Publicado: (2019)

TOPK Affects Autophagy of Skin Squamous Cell Carcinoma by Regulating NF-KB Pathway through HDAC1
por: Li, Juan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dhtooqvbhspvj1jjjqtt03le78